Pfizer’s Centers for Therapeutic Innovation Requests Proposals for Therapeutic Targets (Large Molecule Programs Only)

Pfizer’s Centers for Therapeutic Innovation (CTI) requests proposals for novel therapeutic targets with application across Pfizer's core therapeutic areas:

• Oncology
  • Tumor targeted
  • Immuno-Oncology
  • Cancer vaccines
• Internal medicine
  • Obesity/cachexia
  • Heart failure
  • Diabetic/chronics kidney disease
  • NASH/T2D
• Inflammation & immunology
  • Rheumatology
  • Gastroenterology
  • Medical derm
• Rare disease
  • Cardiology
  • Neuro-musc.
  • Metabolic
  • Hematology

Collaboration with CTI provides access to Pfizer R&D strengths, resources, and capabilities to help guide and advance novel scientific approaches.

• Each investigator is paired with a scientific champion at Pfizer
• Funding is provided for project-specific research in the academic lab
• Complementary biology and drug discovery are performed at Pfizer

Submission process:

• Develop a 2-3 page non-confidential document outlining the scientific background and research synopsis
• Faculty interested in submitting a project should contact [email protected]. Pre-proposals should be reviewed by one of Pfizer’s Emerging Science Leads to determine suitability prior to submission. Formal submission should be routed through Columbia Technology Ventures.
• The deadline to submit pre-proposals to Columbia Technology Ventures is June 21, 2021.
• Please see the Related Documents section of this page for additional information.